Browse

Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study

Cited 72 time in Web of Science Cited 71 time in Scopus
Authors
Lim, Soo; Koo, Bo Kyeong; Cho, Sun Wook; Kihara, Shinji; Funahashi, Tohru; Cho, Young Min; Kim, Seong Yeon; Lee, Hong Kyu; Shimomura, Iichiro; Park, Kyong Soo
Issue Date
2006-12-21
Publisher
Elsevier
Citation
Atherosclerosis. 2008;196(1):398-404
Keywords
Adiponectin/bloodAgedDiabetes Mellitus, Type 2/*blood/complications/ethnologyDiabetic Nephropathies/blood/complications/ethnologyFemaleHumansKaplan-Meiers EstimateKoreaMaleMiddle AgedMyocardial Infarction/blood/complications/ethnologyProportional Hazards ModelsProspective StudiesResistin/*bloodRisk FactorsStroke/blood/complications/ethnology
Abstract
Adiponectin and resistin are proteins that affect insulin resistance and atherosclerosis significantly. We investigated adiponectin and resistin concentrations as predictors of cardiovascular events in Korean patients with type 2 diabetes. The study in 2001 comprised 343 unrelated patients with type 2 diabetes (65+/-9.2 years old). They were followed up for 42 months. The baseline duration of diabetes, smoking status and history of cardiovascular diseases (CVD) were recorded. BMI, blood pressures, HbA1c, lipid profiles, ECG, creatinine and urine microalbumin were measured. Adiponectin and resistin were measured using enzyme-linked immunosorbent assays. The primary endpoint was defined as one of cardiovascular death, myocardial infarct, CABG, stroke, unstable angina or overt nephropathy. Thirty-eight patients (11.1%) experienced primary endpoint during the follow-up. After adjustment for age, sex, BMI, blood pressure and lipid status, participants in the lowest quartile of adiponectin levels compared with the highest had significantly increased risk of primary endpoint (relative risk=3.03; 95% CI 1.09-8.41; p=0.034). In contrast, resistin level had no influence on the risk of primary endpoint. A low level of adiponectin, not resistin, was a significant risk factor for the development of cardiovascular events in these Korean patients with type 2 diabetes.
ISSN
1879-1484 (Electronic)
Language
English
URI
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17178123

http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T12-4MKV2S4-2-3&_cdi=4878&_user=168665&_orig=search&_coverDate=01%2F31%2F2008&_sk=998039998&view=c&wchp=dGLbVlz-zSkzk&md5=7abc08f1c0ef46354165da516c8ae1bc&ie=/sdarticle.pdf

http://hdl.handle.net/10371/67849
DOI
https://doi.org/10.1016/j.atherosclerosis.2006.11.017
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse